Metagenomic Sequencing Market Analysis: Key Segments and Regional Growth Outlook
Author : ashlesha more | Published On : 07 Oct 2026
The global metagenomic sequencing market was valued at USD 2.58 billion in 2025 and is projected to grow from USD 3.03 billion in 2026 to USD 11.03 billion by 2034, registering a 17.5% CAGR from 2026 to 2034. Growing applications in infectious disease diagnostics, drug discovery, antimicrobial resistance surveillance, microbiome research, and environmental analysis are accelerating market expansion.
- Market Size (2025): USD 2.58 Billion
- Market Size (2026): USD 3.03 Billion
- CAGR (Forecast Period): 17.5%
- Forecast Year: 2034
- Projected Market Size (Forecast Year): USD 11.03 Billion
- Dominant Region: North America
- Fastest Growing Region: Asia Pacific
Market Overview
Metagenomic sequencing enables researchers to analyze genetic material from entire microbial communities without requiring individual organisms to be cultured. The technology provides insights into species diversity, functional genes, microbial interactions, and environmental relationships, supporting applications across healthcare, pharmaceuticals, agriculture, biotechnology, and environmental research.
Growth Drivers
The rising number of unexplained infectious disease cases is increasing interest in broad pathogen detection through metagenomic sequencing. Growing cloud-based bioinformatics infrastructure is also improving the capacity to process and analyze large sequencing datasets, supporting wider adoption across clinical and research laboratories.
Challenges
High computational requirements and fragmented bioinformatics workflows remain important challenges. Large sequencing datasets require substantial storage and processing capacity, while differences among analytical pipelines, reference databases, and classification tools can complicate result interpretation and standardization.
Opportunities
Microbiome-based drug discovery represents a significant opportunity for sequencing providers, biotechnology companies, pharmaceutical developers, and research organizations. Agricultural applications are also expanding as metagenomics supports soil microbiome profiling, crop-health analysis, microbial screening, and precision agriculture programs.
Segment Analysis
By product and service, reagents and consumables dominated with a 54.6% share in 2025, while services are projected to grow at the fastest CAGR of 19.3%. By technology, shotgun metagenomic sequencing led with a 41.7% share, while metatranscriptomic sequencing is expected to grow fastest at 20.2% CAGR. By application, drug discovery accounted for the largest share at 30.8%, while clinical diagnostics is projected to register the fastest CAGR of 20.4%.
Regional Analysis
North America held the largest market share of 42.5% in 2025, supported by advanced genomic infrastructure, extensive sequencing research, and growing public-health applications.
Asia Pacific is expected to be the fastest-growing region, with a 20.6% CAGR through 2034. Expanding genomic research capacity, infectious disease surveillance, and bioinformatics infrastructure are supporting regional growth.
Competitive Landscape
The market features sequencing technology providers, genomic service companies, bioinformatics specialists, and life-science organizations. Key companies include:
- BGI Genomics Co., Ltd.
- Oxford Nanopore Technologies Ltd.
- Eurofins Genomics
- Illumina, Inc.
- Macrogen Inc.
- Pacific Biosciences of California, Inc.
- PerkinElmer Inc.
- QIAGEN N.V.
- Swift Biosciences Inc.
- Thermo Fisher Scientific Inc.
Recent Developments
Recent industry activity has focused on improving next-generation sequencing workflows, real-time metagenomic analysis, long-read sequencing, microbial genome assembly, and bioinformatics capabilities. These advances are strengthening applications in pathogen detection, microbiome research, environmental genomics, and clinical diagnostics.
Click to Read the Complete Insights & Report: https://straitsresearch.com/report/metagenomic-sequencing-market
Future Outlook
The metagenomic sequencing market is expected to maintain strong growth through 2034 as sequencing technologies become faster, analytical platforms become more scalable, and applications expand across healthcare, drug discovery, agriculture, and environmental monitoring. Increasing adoption of real-time sequencing and genomic surveillance is expected to further broaden the market's commercial potential.
About Straits Research
Straits Research is a global market intelligence and consulting company providing industry research, strategic insights, market forecasts, competitive analysis, and consulting services across diverse industries. The company delivers data-driven research to help organizations understand emerging market opportunities and make informed business decisions.
